Casper vs Enzyme — how do they compare? Casper trades at Rp32.36 (market cap Rp534,42M, Rp36,72M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Casper is far larger — about 4× Enzyme's market cap, and Casper's circulating supply is 16,6B CSPR versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Casper for 13 Days and Enzyme for 28 Days on average.
| CSPR | MLN | |
|---|---|---|
Market Cap | Rp534,42M | Rp134,13M |
Volume (24h) | Rp36,72M | Rp104,56M |
Circulating Supply | 16,6B CSPR | 3,3M MLN |
Typical Hold Time | 13 Days | 28 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
Casper is a Proof-of-Stake Layer-1 blockchain aimed at bringing real-world assets on-chain. Launched on the mainnet in March 2021, Casper provides infrastructure for tokenized assets, featuring upgradable smart contracts, protocol-level access control, and native support for multiple virtual machines (VMs).
Read more on CSPR →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →